CCL27 and rheumatoid arthritis: An in vitro study found that CTACK/CCL27 significantly inhibited the migration of human subchondral mesenchymal progenitor cells in synovial fluid to the site of microfracture defects, thereby adversely affecting the prognosis of RA patients (30).